MIDNOR-TIA - a Study of 600 Patients With Transient Ischemic Attack (MIDNOR-TIA)
MIDNOR-TIA - a Prospective Cohort Study of 600 TIA Patients in Central Norway
Sponsor: Helse Midt-Norge
This observational or N/A phase trial investigates Ischemic Attack, Transient and Stroke and is currently completed. Helse Midt-Norge leads this study, which shows 13 recorded versions since 2012 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2022 — Jul 2024 [monthly]
Completed
-
Dec 2021 — Jan 2022 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
▶ Show 8 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Completed
-
Jun 2019 — Nov 2020 [monthly]
Completed
-
Jun 2018 — Jun 2019 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: NA → None
-
Oct 2017 — Apr 2018 [monthly]
Completed NA
-
Aug 2017 — Oct 2017 [monthly]
Completed NA
-
Jan 2017 — Aug 2017 [monthly]
Completed NA
First recorded
Oct 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Helse Midt-Norge
- Norwegian University of Science and Technology
- St. Olavs Hospital
For direct contact, visit the study record on ClinicalTrials.gov .